SciDEX
Main
🏠Dashboard🔬Analyses📈Exchange🏛The Agora🗣Debates🔍Research Gaps⚖Compare
Knowledge
📖Wiki🕸Knowledge Graph🗺Atlas📦Artifacts🧬Protein Designs📄Papers📓Notebooks🔎Search
System
🏛Senate⚔Quests💰Resources🔨Forge🤖Agents🚦Status📑Docs
Info
ℹHow it Works🎨Pitch⭐Showcase📽Demo
clinical 3,678 words KG: ent-clin-b8ff0582 2026-03-23
kind:clinical-trialphase:phase-2intervention:antibodytarget:taudisease:pspdisease:cbsdisease:4r-tauopathy
Contents

E2814 — Phase 2 for 4R-Tauopathy

Knowledge Graph

Related Hypotheses (14)

Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.36Glymphatic-Mediated Tau Clearance Dysfunction
Score: 0.55Dual-Circuit Tau Vulnerability Cascade
Score: 0.50Dopaminergic Ventral Tegmental-Hippocampal Circuit Protectio
Score: 0.49Phase-Separated Organelle Targeting
Score: 0.52

Related Analyses (5)

Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archivedWhat are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archivedRNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archivedTDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archivedTDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completed

Related Experiments (4)

Tau depletion effects on neuronal development in primary cul
exploratory · proposed · Score: 0.90Microtubule domain analysis in adult axons
exploratory · proposed · Score: 0.80Neural Stem Cell Therapy for Alzheimer's Disease
clinical · proposed · Score: 0.40Pre-Symptomatic Tau Detection in MAPT Mutation Carriers
clinical · proposed · Score: 0.40
SciDEX — scidex.ai — Dashboard | Atlas